These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 16920077)

  • 1. Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study.
    Amminger GP; Berger GE; Schäfer MR; Klier C; Friedrich MH; Feucht M
    Biol Psychiatry; 2007 Feb; 61(4):551-3. PubMed ID: 16920077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
    Freund-Levi Y; Eriksdotter-Jönhagen M; Cederholm T; Basun H; Faxén-Irving G; Garlind A; Vedin I; Vessby B; Wahlund LO; Palmblad J
    Arch Neurol; 2006 Oct; 63(10):1402-8. PubMed ID: 17030655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regarding "omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study".
    Gilbert DL
    Biol Psychiatry; 2008 Jan; 63(2):e13; author reply e15. PubMed ID: 17555722
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.
    Amminger GP; Schäfer MR; Papageorgiou K; Klier CM; Cotton SM; Harrigan SM; Mackinnon A; McGorry PD; Berger GE
    Arch Gen Psychiatry; 2010 Feb; 67(2):146-54. PubMed ID: 20124114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study.
    Chiu CC; Su KP; Cheng TC; Liu HC; Chang CJ; Dewey ME; Stewart R; Huang SY
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1538-44. PubMed ID: 18573585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.
    da Silva TM; Munhoz RP; Alvarez C; Naliwaiko K; Kiss A; Andreatini R; Ferraz AC
    J Affect Disord; 2008 Dec; 111(2-3):351-9. PubMed ID: 18485485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-3/omega-6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo-controlled trial in children and adolescents.
    Johnson M; Ostlund S; Fransson G; Kadesjö B; Gillberg C
    J Atten Disord; 2009 Mar; 12(5):394-401. PubMed ID: 18448859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Oxford-Durham study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder.
    Richardson AJ; Montgomery P
    Pediatrics; 2005 May; 115(5):1360-6. PubMed ID: 15867048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.
    Akhondzadeh S; Erfani S; Mohammadi MR; Tehrani-Doost M; Amini H; Gudarzi SS; Yasamy MT
    J Clin Pharm Ther; 2004 Apr; 29(2):145-50. PubMed ID: 15068403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study.
    Wasserman S; Iyengar R; Chaplin WF; Watner D; Waldoks SE; Anagnostou E; Soorya L; Hollander E
    Int Clin Psychopharmacol; 2006 Nov; 21(6):363-7. PubMed ID: 17012983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary omega-3 fatty acid supplementation and naproxen treatment in patients with rheumatoid arthritis.
    Kjeldsen-Kragh J; Lund JA; Riise T; Finnanger B; Haaland K; Finstad R; Mikkelsen K; Førre O
    J Rheumatol; 1992 Oct; 19(10):1531-6. PubMed ID: 1464864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omega-3 fatty acids in bipolar disorder: clinical and research considerations.
    Marangell LB; Suppes T; Ketter TA; Dennehy EB; Zboyan H; Kertz B; Nierenberg A; Calabrese J; Wisniewski SR; Sachs G
    Prostaglandins Leukot Essent Fatty Acids; 2006; 75(4-5):315-21. PubMed ID: 16928441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, placebo-controlled study investigating the effects of omega-3 supplementation in children aged 8-10 years from a mainstream school population.
    Kirby A; Woodward A; Jackson S; Wang Y; Crawford MA
    Res Dev Disabil; 2010; 31(3):718-30. PubMed ID: 20171055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms.
    Freund-Levi Y; Basun H; Cederholm T; Faxén-Irving G; Garlind A; Grut M; Vedin I; Palmblad J; Wahlund LO; Eriksdotter-Jönhagen M
    Int J Geriatr Psychiatry; 2008 Feb; 23(2):161-9. PubMed ID: 17582225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omega-3 fatty acids as a treatment for perinatal depression: randomized double-blind placebo-controlled trial.
    Rees AM; Austin MP; Parker GB
    Aust N Z J Psychiatry; 2008 Mar; 42(3):199-205. PubMed ID: 18247194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of the omega-3 fatty acid, eicosapentaenoic acid (EPA) in psychiatric patients: results from a randomized, placebo-controlled trial.
    Emsley R; Niehaus DJ; Oosthuizen PP; Koen L; Ascott-Evans B; Chiliza B; van Rensburg SJ; Smit RM
    Psychiatry Res; 2008 Dec; 161(3):284-91. PubMed ID: 18962989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of large doses of arachidonic acid added to docosahexaenoic acid on social impairment in individuals with autism spectrum disorders: a double-blind, placebo-controlled, randomized trial.
    Yui K; Koshiba M; Nakamura S; Kobayashi Y
    J Clin Psychopharmacol; 2012 Apr; 32(2):200-6. PubMed ID: 22370992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acids in ADHD: plasma profiles in a placebo-controlled study of Omega 3/6 fatty acids in children and adolescents.
    Johnson M; Månsson JE; Ostlund S; Fransson G; Areskoug B; Hjalmarsson K; Landgren M; Kadesjö B; Gillberg C
    Atten Defic Hyperact Disord; 2012 Dec; 4(4):199-204. PubMed ID: 22753087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omega-3 fatty acid supplementation in patients with chronic epilepsy: a randomized trial.
    Yuen AW; Sander JW; Fluegel D; Patsalos PN; Bell GS; Johnson T; Koepp MJ
    Epilepsy Behav; 2005 Sep; 7(2):253-8. PubMed ID: 16006194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omega-3 fatty acids in ADHD and related neurodevelopmental disorders.
    Richardson AJ
    Int Rev Psychiatry; 2006 Apr; 18(2):155-72. PubMed ID: 16777670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.